Department of Neurology;
Drum Tower Hospital;
Medical School of Nanjing University;
Nanjing;
Jiangsu Province;
China;
The State Key Laboratory of Pharmaceutical Biotechnology;
Nanjing University;
Nanjing;
Jiangsu Province;
China;
Jiangsu Key Laboratory for Molecular Medicine;
Nanjing;
Jiangsu Province;
China;
Taizhou People’s Hospital;
Taizhou;
Jiangsu Province;
China;
Department of Medicinal Chemistry;
School of Pharmacy;
Nanjing Medical University;
Nanjing;
Jiangsu Province;
China;
Akt; Alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; Nrf2; oxidative stress; treatment; ZL006;